Citation: Ln. Harris et al., INDUCTION OF SENSITIVITY TO DOXORUBICIN AND ETOPOSIDE BY TRANSFECTIONOF MCF-7 BREAST-CANCER CELLS WITH HEREGULIN BETA-2, Clinical cancer research, 4(4), 1998, pp. 1005-1012
Citation: Ln. Harris et al., INDUCTION OF SENSITIVITY TO DOXORUBICIN AND ETOPOSIDE BY TRANSFECTIONOF MCF-7 BREAST-CANCER CELLS WITH HEREGULIN BETA-2, Clinical cancer research, 4(4), 1998, pp. 1005-1012
Authors:
WANG F
WEAVER VM
PETERSEN OW
LARABELL CA
DEDHAR S
BRIAND P
LUPU R
BISSEL MJ
Citation: F. Wang et al., RECIPROCAL INTERACTIONS BETWEEN B1-INTEGRIN AND EGFR IN 3-DIMENSIONALCULTURES - A NEW PERSPECTIVE IN NORMAL AND MALIGNANT BREAST EPITHELIAL BIOLOGY, Molecular biology of the cell, 9, 1998, pp. 2477-2477
Authors:
HARTMANN F
HORAK EM
CHO C
LUPU R
BOLEN JB
STETLERSTEVENSON MA
PFREUNDSCHUH M
WALDMANN TA
HORAK ID
Citation: F. Hartmann et al., EFFECTS OF THE TYROSINE-KINASE INHIBITOR GELDANAMYCIN ON LIGAND-INDUCED HER-2 NEU ACTIVATION, RECEPTOR EXPRESSION AND PROLIFERATION OF HER-2-POSITIVE MALIGNANT-CELL LINES/, International journal of cancer, 70(2), 1997, pp. 221-229
Citation: Fk. Guerravladusic et R. Lupu, TRANSFECTION OF HRG0-BETA-2 INDUCES CELLULAR-CHANGES IN SKBR-3 HUMAN BREAST-CANCER CELLS, Molecular biology of the cell, 7, 1996, pp. 869-869
Authors:
SEPPLORENZINO L
EBERHARD I
MA ZP
CHO C
SERVE H
LIU F
ROSEN N
LUPU R
Citation: L. Sepplorenzino et al., SIGNAL-TRANSDUCTION PATHWAYS INDUCED BY HEREGULIN IN MDA-MB-453 BREAST-CANCER CELLS, Oncogene, 12(8), 1996, pp. 1679-1687
Authors:
GOLDSTEIN J
GRAZIANO RF
SUNDARAPANDIYAN K
LUPU R
DEO Y
Citation: J. Goldstein et al., CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN WHICH MEDIATES CYTOLYSIS OF HER2-OVEREXPRESSING TUMOR-CELLS BY TYPE-I FC-GAMMA RECEPTOR (FC-GAMMA-RI)-EXPRESSING EFFECTOR-CELLS, The FASEB journal, 10(6), 1996, pp. 2020-2020
Authors:
CARDILLO M
YANKELEVICH B
MAZUMDER A
LUPU R
Citation: M. Cardillo et al., HEREGULIN INDUCES INCREASE IN SENSITIVITY OF AN ERBB-2-OVEREXPRESSINGBREAST-CANCER CELL-TYPE TO LYSIS BY LYMPHOKINE-ACTIVATED KILLER-CELLS, Cancer immunology and immunotherapy, 43(1), 1996, pp. 19-25
Authors:
LUPU R
CARDILLO M
CHO C
HARRIS L
HIJAZI M
PEREZ C
ROSENBERG K
YANG D
TANG C
Citation: R. Lupu et al., THE SIGNIFICANCE OF HEREGULIN IN BREAST-CANCER TUMOR PROGRESSION AND DRUG-RESISTANCE, Breast cancer research and treatment, 38(1), 1996, pp. 57-66
Authors:
SACEDA M
GRUNT TW
COLOMER R
LIPPMAN ME
LUPU R
MARTIN MB
Citation: M. Saceda et al., REGULATION OF ESTROGEN-RECEPTOR CONCENTRATION AND ACTIVITY BY AN ERBBHER LIGAND IN BREAST-CARCINOMA CELL-LINES/, Endocrinology, 137(10), 1996, pp. 4322-4330
Authors:
TANG CK
PEREZ C
GRUNT T
WAIBEL C
CHO C
LUPU R
Citation: Ck. Tang et al., INVOLVEMENT OF HEREGULIN-BETA-2 IN THE ACQUISITION OF THE HORMONE-INDEPENDENT PHENOTYPE OF BREAST-CANCER CELLS, Cancer research, 56(14), 1996, pp. 3350-3358
Authors:
LUPU R
CARDILLO M
HARRIS L
HIJAZI M
ROSENBERG K
Citation: R. Lupu et al., INTERACTION BETWEEN ERBB- RECEPTORS AND HEREGULIN IN BREAST-CANCER TUMOR PROGRESSION AND DRUG-RESISTANCE, Seminars in cancer biology, 6(3), 1995, pp. 135-145
Authors:
AVILA MA
VELASCO JA
CHO C
LUPU R
WEN DZ
NOTARIO V
Citation: Ma. Avila et al., HYPERACTIVE AUTOCRINE LOOP MEDIATED BY A NDF-RELATED FACTOR IN NEOPLASTIC HAMSTER-EMBRYO FIBROBLASTS EXPRESSING AN ACTIVATED CPH ONCOGENE, Oncogene, 10(5), 1995, pp. 963-971
Authors:
ELIZALDE PV
GUERRA FK
GRAVANO M
LANARI C
LIPPMAN ME
CHARREAU EH
LUPU R
Citation: Pv. Elizalde et al., CORRELATION OF TGF-BETA(1) EXPRESSION WITH MEDROXIPROGESTERONE ACETATE RESPONSIVENESS IN MOUSE MAMMARY ADENOCARCINOMAS, Cancer investigation, 13(2), 1995, pp. 173-180
Authors:
GRUNT TW
SACEDA M
MARTIN MB
LUPU R
DITTRICH E
KRUPITZA G
HARANT H
HUBER H
DITTRICH C
Citation: Tw. Grunt et al., BIDIRECTIONAL INTERACTIONS BETWEEN THE ESTROGEN-RECEPTOR AND THE C-ERBB-2 SIGNALING PATHWAYS - HEREGULIN INHIBITS ESTROGENIC EFFECTS IN BREAST-CANCER CELLS, International journal of cancer, 63(4), 1995, pp. 560-567
Authors:
BACUS SS
GUDKOV AV
ZELNICK CR
STERN RK
CHIN DM
LUPU R
YARDEN Y
Citation: Ss. Bacus et al., NEU DIFFERENTIATION FACTOR (NDF HEREGULIN) INDUCES EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) - IMPLICATIONS TO MAMMARY-TUMORS, Journal of cellular biochemistry, 1994, pp. 228-228
Citation: M. Cardillo et al., SIGNIFICANCE OF ERBB-2 RECEPTOR AND GP30 LIGAND COEXPRESSION IN BREAST-CANCER PATIENTS, Journal of cellular biochemistry, 1994, pp. 229-229
Citation: C. Cho et al., GENERATION AND CHARACTERIZATION OF NEUTRALIZING ANTIBODIES WHICH RECOGNIZE THE ERBB-2 LIGAND, GP30, Journal of cellular biochemistry, 1994, pp. 246-246
Authors:
STEPHENSON PA
ANGHELESCU C
BOBE N
CIOMARTAN T
GAISTEANU M
FUMAREL S
GOLDIS C
GEORGESCU A
IONESCU M
IORGULESCU D
LUPU R
MCCREERY R
MCKAY S
MANESCU V
MIHAI B
MOLDOVANU F
MOLDOVAN Z
MOROSAM I
NANU R
NICOLAU A
PALIKARI G
PASCU C
POPA S
POPESCU P
RAICAN A
STANESCU A
STATIVA E
STOICA M
Citation: Pa. Stephenson et al., THE CAUSES OF CHILDRENS INSTITUTIONALIZATION IN ROMANIA, Child care health and development, 20(2), 1994, pp. 77-88
Authors:
STAEBLER A
SOMMERS C
MUELLER SC
BYERS S
THOMPSON EW
LUPU R
Citation: A. Staebler et al., MODULATION OF BREAST-CANCER PROGRESSION AND DIFFERENTIATION BY THE GP30 NEREGULIN/, Breast cancer research and treatment, 31(2-3), 1994, pp. 175-182
Citation: R. Colomer et al., ERBB-2 ANTISENSE OLIGONUCLEOTIDES INHIBIT THE PROLIFERATION OF BREAST-CARCINOMA CELLS WITH ERBB-2 ONCOGENE AMPLIFICATION, British Journal of Cancer, 70(5), 1994, pp. 819-825
Citation: R. Lupu et Me. Lippman, THE ROLE OF ERBB2-SIGNAL TRANSDUCTION PATHWAYS IN HUMAN BREAST-CANCER, Breast cancer research and treatment, 27(1-2), 1993, pp. 83-93
Authors:
NOGUCHI M
MURAKAMI M
BENNETT W
LUPU R
HUI F
HARRIS CC
GERWIN BI
Citation: M. Noguchi et al., BIOLOGICAL CONSEQUENCES OF OVEREXPRESSION OF A TRANSFECTED C-ERBB-2 GENE IN IMMORTALIZED HUMAN BRONCHIAL EPITHELIAL-CELLS, Cancer research, 53(9), 1993, pp. 2035-2043